Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Baltimore, MD
NPI: 1386643450Looking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardDC State Medical License
MD State Medical License
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.
Authors: Aaron Rapoport, Carl June, Bruce Levine
Publication Date: 2015-01-30
Single center experience with total body irradiation and melphalan (TBI-MEL) myeloablative conditioning regimen for allogeneic stem cell transplantation (SCT) in patients with refractory hematologic malignancies.
Authors: Aaron Rapoport, Bhavana Bhatnagar
Publication Date: 2013-05-16
Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.
Authors: Aaron Rapoport, Carl June, Bruce Levine
Publication Date: 2014-02-13
Lead Sponsor: John Mascarenhas
Collaborators: National Cancer Institute (NCI), Novartis, Incyte Corporation, Myeloproliferative Disorders-Research Consortium
Intervention / Treatment: DRUG: Ruxolitinib Pre- Hematopoietic cell transplantation (HCT)